CareCloud (CCLD) director gets 6,250 vested shares in equity grant

Rhea-AI Filing Summary

CareCloud, Inc. director Anne Busquet reported a routine equity award vesting and conversion. On January 31, 2026, 6,250 restricted stock units vested and converted into 6,250 shares of common stock at a price of $0.00 under the company’s Amended and Restated Equity Incentive Plan, without payment by Busquet.

After this transaction, she directly holds 287,638 shares of common stock and 33,750 restricted stock units, reflecting ongoing participation in CareCloud’s long‑term incentive program rather than an open‑market purchase or sale.

Insider Trade Summary

6,250 shares exercised/converted

Mixed 2 txns

Insider BUSQUET ANNE

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	6,250	$0.00	--
Exercise	Common Stock	6,250	$0.00	--

Holdings After Transaction: Restricted Stock Unit — 33,750 shares (Direct); Common Stock — 287,638 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BUSQUET ANNE

(Last) (First) (Middle)

7 CLYDE ROAD

(Street)

SOMERSET NJ 08873

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CareCloud, Inc. [ CCLD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/31/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/31/2026		M		6,250	A	$0(1)	287,638	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0(1)	01/31/2026		M			6,250	(1)	(1)	Common Stock	6,250	$0(1)	33,750	D

Explanation of Responses:

1. Represents the conversion upon vesting of restricted stock units into common stock on January 31, 2026. These restricted stock units and the shares of common stock issued upon vesting of such units were acquired under the Company's Amended and Restated Equity Incentive Plan, without payment by the reporting person.

	/s/ Norman Roth Attorney-In-Fact for Anne Busquet	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CareCloud (CCLD) director Anne Busquet report?

CareCloud director Anne Busquet reported vesting of 6,250 restricted stock units that converted into 6,250 common shares. The conversion occurred on January 31, 2026, under CareCloud’s Amended and Restated Equity Incentive Plan as a stock-based compensation event rather than a market trade.

Did Anne Busquet pay for the CareCloud (CCLD) shares received in this Form 4?

No, Anne Busquet did not pay cash for these shares. The 6,250 restricted stock units converted into common stock at a reported price of $0.00, reflecting an equity incentive grant issued under CareCloud’s Amended and Restated Equity Incentive Plan without payment by the reporting person.

How many CareCloud (CCLD) common shares does Anne Busquet own after this transaction?

After the January 31, 2026 transaction, Anne Busquet directly owns 287,638 shares of CareCloud common stock. This updated ownership figure includes the 6,250 shares received upon vesting and conversion of restricted stock units reported in the Form 4 filing as equity compensation.

What happened to Anne Busquet’s restricted stock units in CareCloud (CCLD)?

On January 31, 2026, 6,250 of Anne Busquet’s restricted stock units vested and converted into 6,250 common shares. Following this equity award vesting, she still holds 33,750 restricted stock units, all granted under CareCloud’s Amended and Restated Equity Incentive Plan.

Is the CareCloud (CCLD) Form 4 for Anne Busquet a stock sale or purchase?

The Form 4 reflects neither a purchase nor an open-market sale. It reports the vesting and conversion of 6,250 restricted stock units into common stock at $0.00, issued under CareCloud’s equity incentive plan as compensation rather than a discretionary trading transaction.